Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.
I am still trying to come to terms with the obsession on timescales and how the whole company is apparently collapsing if things don’t arrive overnight.
As an example, AS forecasting a couple of weeks in LFT update. If it doesn’t arrive bang on the money, derampers assume it’s completely goosed and never going to arrive. Absolute lunacy.
IMO we are yet to see the worst of Covid. Almost everyone coming out of lockdown is going back in within a matter of weeks. I genuinely fear the worst for global economies with the current testing malpractice. I think there is little ambiguity that you can only control a virus if you know who has it now.
Even if there were a shedload of competitors releasing projects, the global demand for these things outstrip almost every other tangible good on earth. Testing is going to be central to societal and economic rebuilding for the next few years.
I’d rather have a top quality product in September than a shoddy release in August. You only get one chance at a first
Impression.
alwayswinning- just because Avacta diversification doesn’t suit your agenda, doesn’t mean it’s not a financially viable proposition to the org.
Re: the tweet being desperate. You’re entitled to your opinion. Sona Nanotech produced their results, and it’s commonly known that a saliva test is even more accurate.
Of course, these things take time. Haven’t you realised that poor quality tests have contributed to where the world is today?
Onwards and upwards - Avacta personify the old adage of ‘if a jobs worth doing, do it right or not at all’
All the best with your investments but more importantly your health.
The virus is still sadly ravaging through us globally. However, we are about to announce:
Global best in class POC spit test
Covid neutralising therapy
BAMS test
Wastewater defection
Future cancer neutralisation
We are on the cusp of offering major respite against the two most talked about diseases in the world.
It’s been a nerve wrecking couple of months but I sense something significant is in the offing.
We have seen time and time again this can and will erupt on positive news. Major LFT news/neutralising therapy is going to take this through the roof.
Irrespective of whatever point it lands this year, our revenue streams for future r&d have the potential to take us here:
Netflix's Price
June 23 ,2020: $466.26
Aug. 03 ,2012: $7.7
Shopify's Price
June 23 ,2020: $911.34
Feb. 12 ,2016: $19.33
Domino's' Price
June 23 ,2020: $377.55
July 16 ,2010: $10.37
Amazon's Price
June 23 ,2020: $2764.41
July 30 ,2010: $117.89
NK1234 - whilst I agree this is a likely lifecycle, it will take until Nov/Dec.
Not to worry as Covid is going nowhere fast. In 6 months Avacta will once again be at a considerably different share price to today’s, just as it is in comparison to the share price at the beginning of the year.
The whole market knows it. Wise people are preying on the weak who lack the patience and foresight to go the distance.
I can’t help but think people who bottle it now will be kicking themselves in the future.
Evening all,
Been quite comical watching some of the SP activity and exchange of comments today.
Essentially, from what I can see, is derampers feel there is a correlation between Avacta building relationships for a new revenue stream and a failure of the LFT.
When you have a high performing propriety asset, that has the ability to diversity, you capitalise. This is literally the very being of a private sector organisation.
There is absolutely zero rationale behind anyone suggesting the LFT is in turmoil. The MMs have had an absolute field day again today by pulling the pants down of short term investors who lack the patience required to see best in class products come to fruition.
The experienced members of the camp will have little issue processing this information objectively, knowing it has sweet FA to do with the LFT. It’s simply another cash cow to be realised in the fight against Covid.
Holders will be rewarded very soon. I agree with Myles when I say a major re-rate will be here soon.
All the best and happy days for those of you taking the opportunity to capitalise on more shares
Morning folks,
Been keeping quiet here over the past few weeks, but watching intently.
It’s interesting to see the mood in the camp. The current negative SP fluctuation is purely down to impatience.
There is no other logic for it, as we are actually closer to good news than we were at last Fridays 139p close.
I know it can sometimes be difficult, but try to think objectively. Covid is still absolutely booming and the demand for our tests has never been higher, as proven by the Sona SP rise.
The Sona SP rise following their announcement was essentially like an RNS for the smart holders of Avacta.
I’ve absolutely no qualms whatsoever now and have no issue sitting on my investment, as it’s been proven that you can and will be left behind the second big news lands.
I also find it refreshing that Avacta aren’t at the mercy of the stock market. Clearly, they are very busy in prioritising things that will take care of their future. Appeasing Johnny come lately investors on LSE is as close to the lowest priority as you will find.
The work they are doing in the background, re product refinement and partnership discussions are immensely taxing. To do it right takes time, as does being an investor on the stock market.
Have a good weekend.
Evening folks,
Hope everyone is keeping safe and in good health.
As somebody who has openly criticised Alistair Smiths public speaking, I have to take my hat off to him this evening. That was a first class delivery whilst not getting carried away.
Alistair appears to be growing in confidence. In particular, towards the potential of the LFD. The demand for antigen testing is so apparent. Antibody testing has its values but antigen is key to sustainable monitoring of Covid. The lack of existing dominance in a largely untapped market is mouth watering for me. Those who questioned the medusa agreement will realise how cute this decision was, once we get to mass manufacturing stage. There is little ambiguity that boohoo are experts in repeatability in mass manufacturing and delivery.
What’s more, the future of the company has never been brighter. The revenues raised by the forthcoming LFD are going to be transformational in supporting our innovative work in the chemotherapy space.
I am really struggling to comprehend how much of a game changer Avacta might become.
In the worlds of Mel Gibson in Braveheart “Hoooooollllldddd!!!!!!!”
It doesn’t even need to be the world’s first.
All we need is for it to translate to considerable revenue so the company can invest in further r & d.
What ties with revenue? Demand. The whole world needs effective on the spot testing, with high specificity.
Being completely frank, you wouldn’t even need the best in class test per se.
There is plenty water in the well for many manufacturers.
I’m just not sure the rest of them have the additional long term revenue streams, like Covid and Cancer therapies.
Avacta genuinely does have the potential to be revolutionary.
This week was the highest ever for new Covid cases.
Wake up and smell the coffee. The demand is not going to diminish any time soon.
You see many companies releasing poor tests. The cost of doing it wrong outstrips the benefits of being first past the post.
Antigen testing is going to be key for successful lifting of lockdowns.
Always winning - you do realise the share price literally doubled in that period too?
Welcome to the stock market. Share prices fluctuate. Set automatic cash out targets that takes care of it for you. If you can’t handle being patient, get your money on the horses.
Just remember, when it’s gone it’s gone but on with Avacta, the best is yet to come, even after a stale few weeks.
Doesn’t take a genius to work out that investing involves patience.
The daily fluctuations are now beyond obvious.
Traders sell on open to try and instil fear. This tricks people in to selling and the SP drops and they buy back in around 11-1pm for the afternoon rise.
You do realise you can stop this by not selling your shares, right?
Been here a hundred times before and the same thing happens every time.
As soon as there’s some uncertainty, the shortest are out in their droves to inspire fear.
There is absolutely zero rationale behind selling on a panic when absolutely nothing new has happened re: the company. If anything, we are in a stronger position given the prevalence of Covid and other tests which have proven to be so poor.
It’s up to you how you look after your portfolio, but share prices are forever temporary.
Gentle reminder that today provided the highest number of new Covid cases globally.
Bearing in mind must of the world has been in lockdown.
Just let that sink in when considering the state of the market we are breaking in to.
As per my post earlier:
Has anything in the company changed? No
Can we control the virus with current measures? No
Are there second waves globally? Yes
Is there an available immediate POC saliva test dominating the global market? No
Is avacta closer to achieving their goal of LFT? Yes
Is there a vaccine? No
Is avacta working on drug treatment? Yes
Has this been scientifically validated? Yes
Are the worlds largest pharmas looking to expand here? Yes
Does insider trading exist? Yes
Does that mean they can pair with shorters to scratch each other’s back? Yes
Does this mean avacta is going to fail? No
Infact, does this mean that what we are seeing is to provide an opportunity for professional traders to expand their wealth, due to preying on the week via the art of skullduggery? Yes
Will you make money holding on to avacta shares? Yes
Will this happen overnight? No
Have you made the mistake of panicking when similar
Sp behaviour took place place and lived to regret it? Yes
Do we deserve an RNS? No
Will good news come in the future? Yes
There will be no RNS tomorrow. We got one last week re the LFT. It will take time to improve the prototype.
Just sit tight and be patient. We’ve got three major revenue streams in the pipeline but it’s going to take a bit longer to realise their potential.
Folk with ants in their pants shouldn’t invest.